Literature DB >> 26849150

2-Bromo-6-isocyanopyridine as a Universal Convertible Isocyanide for Multicomponent Chemistry.

Gydo van der Heijden1, J A W Sjaak Jong1, Eelco Ruijter1, Romano V A Orru1.   

Abstract

The development of 2-isocyanopyridines as novel convertible isocyanides for multicomponent chemistry is reported. Comparison of 12 representatives of this class revealed 2-bromo-6-isocyanopyridine as the optimal reagent in terms of stability and synthetic efficiency. It combines sufficient nucleophilicity with good leaving group capacity of the resulting amide moiety under both basic and acidic conditions. To demonstrate the practical utility of this reagent, an efficient two-step synthesis of the potent opioid carfentanil is presented.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26849150     DOI: 10.1021/acs.orglett.6b00091

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  5 in total

Review 1.  Tetrazoles via Multicomponent Reactions.

Authors:  Constantinos G Neochoritis; Ting Zhao; Alexander Dömling
Journal:  Chem Rev       Date:  2019-02-01       Impact factor: 60.622

Review 2.  Two decades of recent advances of Ugi reactions: synthetic and pharmaceutical applications.

Authors:  Manar Ahmed Fouad; Hamida Abdel-Hamid; Mohammed Salah Ayoup
Journal:  RSC Adv       Date:  2020-11-23       Impact factor: 4.036

Review 3.  Recent Advances in One-Pot Modular Synthesis of 2-Quinolones.

Authors:  Wan Pyo Hong; Inji Shin; Hee Nam Lim
Journal:  Molecules       Date:  2020-11-20       Impact factor: 4.411

4.  A trustworthy mechanochemical route to isocyanides.

Authors:  Francesco Basoccu; Federico Cuccu; Federico Casti; Rita Mocci; Claudia Fattuoni; Andrea Porcheddu
Journal:  Beilstein J Org Chem       Date:  2022-06-22       Impact factor: 2.544

Review 5.  Multicomponent Reactions for the Synthesis of Active Pharmaceutical Ingredients.

Authors:  Ángel Cores; José Clerigué; Emmanuel Orocio-Rodríguez; J Carlos Menéndez
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.